Agreed,
While everyone (including me) was expecting a more conclusive announcement around full submission, this announcement yesterday is factually and logically the next step for MSB and I think legally this is what they had to say to factually protect themselves.
There is some next steps that are out their control and now it is with the FDA to act on the submitted data and ideally in line with what they have been working with MSB on over the last 2 years in response to the CRL items. Logically 2 years off work should she see a payoff.
I dare say anticipation now will see us move back above $1 soon enough.
Ann: Submits New Information to FDA IND File for SR-aGVHD, page-137
-
- There are more pages in this discussion • 440 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |